Cellosaurus cell line HChol-Y1 (CVCL_M256) (original) (raw)

Cell line name

HChol-Y1

Accession

CVCL_M256

To cite this cell line use: HChol-Y1 (RRID:CVCL_M256)

Comments

Group: Serum/protein free medium cell line.
Population: Japanese.
Doubling time: 52 hours (PubMed=2989602).
Derived from site: In situ; Liver; UBERON=UBERON_0002107.

Disease

Intrahepatic cholangiocarcinoma (NCIt: C35417)
Cholangiocarcinoma (ORDO: Orphanet_70567)

Species of origin

Homo sapiens (Human) (NCBI Taxonomy: 9606)

Sex of cell

Sex unspecified

Age at sampling

Age unspecified

Category

Cancer cell line

Publications

PubMed=2989602; DOI=10.1093/jnci/75.1.29
Nozomi Yamaguchi, Hiroyuki Morioka, Hisanao Ohkura, Setsuo Hirohashi, Keiichi Kawai;
Establishment and characterization of the human cholangiocarcinoma cell line HChol-Y1 in a serum-free, chemically defined medium.
J. Natl. Cancer Inst. 75:29-35(1985)

CLPUB00275
Sebastian Zach, Emrullah Birgin, Felix Ruckert;
Primary cholangiocellular carcinoma cell lines.
J. Stem Cell Res. Transplant. 2:1013-1013(2015)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155
Abdulkadir Isidan, Ali Yenigun, Daiki Soma, Eric Aksu, Kevin Lopez, Yujin Park, Arthur Cross-Najafi, Ping Li, Debjyoti Kundu, Michael G. House, Sanjukta Chakraborty, Shannon Glaser, Lindsey Kennedy, Heather Francis, Wen-Jun Zhang, Gianfranco D. Alpini, Burcin Ekser; Show fewer authors
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)

Cross-references

Encyclopedic resources

Wikidata; Q54881878

Entry history

Entry creation

05-Nov-2013

Last entry update

29-Jun-2023

Version number